Cellectar biosciences reports q3 loss per share of $0.42

Cellectar reports third quarter 2019 financial results and provides a corporate update.q3 loss per share $0.42.q3 earnings per share estimate $-0.38 -- refinitiv ibes data.as of september 30, 2019, cash & cash equivalents were approximately $13.3 million.

CLRB Ratings Summary

CLRB Quant Ranking